Phosphorylation of eNOS initiates excessive NO production in early phases of portal hypertension - PubMed (original) (raw)
. 2002 Jun;282(6):H2084-90.
doi: 10.1152/ajpheart.00675.2001.
Affiliations
- PMID: 12003815
- DOI: 10.1152/ajpheart.00675.2001
Free article
Phosphorylation of eNOS initiates excessive NO production in early phases of portal hypertension
Yasuko Iwakiri et al. Am J Physiol Heart Circ Physiol. 2002 Jun.
Free article
Abstract
Akt, also known as protein kinase B, is a serine/threonine kinase. Akt becomes active when phosphorylated by the activation of receptor tyrosine kinases, G protein-coupled receptors, and mechanical forces such as shear stress. Studies in vitro have shown that Akt can directly phosphorylate endothelial nitric oxide (NO) synthase (eNOS) and activate the enzyme, leading to NO production. The aim of this study was to test the hypothesis that the phosphorylation of eNOS plays a role in the enhanced NO production observed in early portal hypertension. Male Sprague-Dawley rats were subjected to either sham or portal vein ligation (PVL), and mesenteric arterial beds were used for ex vivo perfusion studies. Mesenteric arterial beds from PVL rats had an approximately 60-70% decrease in response to methoxamine (an alpha(1)-agonist and vasoconstrictor) compared with the sham group (P < 0.01). When N(G)-monomethyl-L-arginine (a NOS inhibitor) was added to the perfusion, the difference in perfusion pressure between the two groups was abolished, suggesting that enhanced NO production in the PVL group blunted the response to the vasoconstrictor. The reduced responsiveness in PVL was not due to changes in eNOS expression but was due to an increase in enzyme-specific activity, suggesting posttranslational modification of eNOS. The phosphorylation of eNOS at Ser(1176) was significantly increased by twofold (P < 0.05) in the PVL group. Furthermore, PVL significantly increased Akt phosphorylation (an active form of Akt) by threefold (P < 0.05). When vessels were treated with wortmannin (10 nM) to block the phosphatidylinositol-3-OH-kinase/Akt pathway, NO-induced vasodilatation was significantly reduced. These results suggest that the phosphorylation of eNOS by Akt activates the enzyme and may be the first step leading to an initial increase in NO production in portal hypertension.
Similar articles
- Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation.
Gao F, Gao E, Yue TL, Ohlstein EH, Lopez BL, Christopher TA, Ma XL. Gao F, et al. Circulation. 2002 Mar 26;105(12):1497-502. doi: 10.1161/01.cir.0000012529.00367.0f. Circulation. 2002. PMID: 11914261 - Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats.
Tsai MH, Iwakiri Y, Cadelina G, Sessa WC, Groszmann RJ. Tsai MH, et al. Gastroenterology. 2003 Nov;125(5):1452-61. doi: 10.1016/j.gastro.2003.07.014. Gastroenterology. 2003. PMID: 14598261 - Shear stress stimulates phosphorylation of endothelial nitric-oxide synthase at Ser1179 by Akt-independent mechanisms: role of protein kinase A.
Boo YC, Sorescu G, Boyd N, Shiojima I, Walsh K, Du J, Jo H. Boo YC, et al. J Biol Chem. 2002 Feb 1;277(5):3388-96. doi: 10.1074/jbc.M108789200. Epub 2001 Nov 29. J Biol Chem. 2002. PMID: 11729190 - NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats.
Wiest R, Shah V, Sessa WC, Groszmann RJ. Wiest R, et al. Am J Physiol. 1999 Apr;276(4):G1043-51. doi: 10.1152/ajpgi.1999.276.4.G1043. Am J Physiol. 1999. PMID: 10198349 - Activation of eNOS in rat portal hypertensive gastric mucosa is mediated by TNF-alpha via the PI 3-kinase-Akt signaling pathway.
Kawanaka H, Jones MK, Szabo IL, Baatar D, Pai R, Tsugawa K, Sugimachi K, Sarfeh IJ, Tarnawski AS. Kawanaka H, et al. Hepatology. 2002 Feb;35(2):393-402. doi: 10.1053/jhep.2002.30958. Hepatology. 2002. PMID: 11826414
Cited by
- Gastro‑oesophageal reflux disease in liver cirrhosis: Possible pathogenesis and clinical intervention (Review).
Yu F, Zhu Y, Li N, Fu HF, Jiang Z, Zhang XY, Zeng L, Hu XY. Yu F, et al. Exp Ther Med. 2023 Jul 12;26(3):414. doi: 10.3892/etm.2023.12113. eCollection 2023 Sep. Exp Ther Med. 2023. PMID: 37559931 Free PMC article. Review. - Alterations in heparan sulfate proteoglycan synthesis and sulfation and the impact on vascular endothelial function.
Pretorius D, Richter RP, Anand T, Cardenas JC, Richter JR. Pretorius D, et al. Matrix Biol Plus. 2022 Sep 7;16:100121. doi: 10.1016/j.mbplus.2022.100121. eCollection 2022 Dec. Matrix Biol Plus. 2022. PMID: 36160687 Free PMC article. Review. - Tetrahydrobiopterin paradoxically mediates cardiac oxidative stress and mitigates ethanol-evoked cardiac dysfunction in conscious female rats.
Yao F, Abdel-Rahman AA. Yao F, et al. Eur J Pharmacol. 2021 Oct 15;909:174406. doi: 10.1016/j.ejphar.2021.174406. Epub 2021 Aug 6. Eur J Pharmacol. 2021. PMID: 34364878 Free PMC article. - Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension.
Kreisel W, Schaffner D, Lazaro A, Trebicka J, Merfort I, Schmitt-Graeff A, Deibert P. Kreisel W, et al. Int J Mol Sci. 2020 Aug 28;21(17):6223. doi: 10.3390/ijms21176223. Int J Mol Sci. 2020. PMID: 32872119 Free PMC article. Review. - Role of Gender in Regulation of Redox Homeostasis in Pulmonary Arterial Hypertension.
Rafikov R, James J, McClain N, Tofovic SP, Rafikova O. Rafikov R, et al. Antioxidants (Basel). 2019 May 16;8(5):135. doi: 10.3390/antiox8050135. Antioxidants (Basel). 2019. PMID: 31100969 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
- HL-61371/HL/NHLBI NIH HHS/United States
- HL-64793/HL/NHLBI NIH HHS/United States
- R01 HL-57665/HL/NHLBI NIH HHS/United States
- T32-DK-07356-23/DK/NIDDK NIH HHS/United States
- T32-HL-10183/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources